| Primary |
| Hypocalcaemia |
40.0% |
| Hypophosphataemia |
40.0% |
| Dehydration |
20.0% |
|
| Extravasation |
25.0% |
| Hyperkalaemia |
25.0% |
| Nephrocalcinosis |
25.0% |
| Polyomavirus-associated Nephropathy |
25.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
51.9% |
| Pneumonia |
15.7% |
| Product Used For Unknown Indication |
15.7% |
| Parenteral Nutrition |
10.2% |
| Rickets |
3.7% |
| Electrolyte Substitution Therapy |
0.9% |
| Hypophosphataemia |
0.9% |
| Medical Diet |
0.5% |
| Toxic Epidermal Necrolysis |
0.5% |
|
| Toxic Epidermal Necrolysis |
60.0% |
| Nephrocalcinosis |
12.0% |
| Enterobacter Infection |
4.0% |
| Hypotension |
4.0% |
| Nephrolithiasis |
4.0% |
| Nephropathy |
4.0% |
| Overdose |
4.0% |
| Palpitations |
4.0% |
| Wheezing |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.7% |
| Drug Use For Unknown Indication |
26.7% |
| Nausea |
4.8% |
| Hypertension |
4.7% |
| Pain |
4.3% |
| Constipation |
3.9% |
| Multiple Myeloma |
3.3% |
| Prophylaxis |
3.3% |
| Supplementation Therapy |
3.0% |
| Premedication |
2.8% |
| Infection |
2.7% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Renal Transplant |
1.7% |
| Nuclear Magnetic Resonance Imaging |
1.7% |
| Anaemia |
1.6% |
| Dyspepsia |
1.3% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Seasonal Allergy |
1.3% |
| Insomnia |
1.1% |
| Infection Prophylaxis |
1.1% |
|
| Vomiting |
15.4% |
| Sepsis |
9.2% |
| Skin Ulcer |
7.7% |
| Febrile Neutropenia |
6.2% |
| Septic Shock |
5.4% |
| Wound Infection Staphylococcal |
5.4% |
| Renal Failure |
4.6% |
| Tachycardia |
4.6% |
| Thrombocytopenia |
4.6% |
| Diarrhoea |
3.8% |
| Electrocardiogram Qt Corrected Interval Prolonged |
3.8% |
| Urinary Tract Infection |
3.8% |
| Viral Haemorrhagic Cystitis |
3.8% |
| Appendicitis Perforated |
3.1% |
| Death |
3.1% |
| Dehydration |
3.1% |
| Erectile Dysfunction |
3.1% |
| Failure To Thrive |
3.1% |
| Labile Hypertension |
3.1% |
| Sinus Tachycardia |
3.1% |
|
